Paper
Organic & Biomolecular Chemistry
(m, 4H), 7.47–7.31 (m, 11H), 7.19 (d, J = 2.4 Hz, 1H), 7.11–7.06 132.1, 128.4, 128.2, 128.1, 124.4, 118.0, 109.8, 72.2, 67.0, 56.0,
(dd, J = 2.4, 8.7 Hz, 1H), 7.03–6.92 (m, 1H), 5.28–5.20 (m, 2H), 55.1, 43.6, 25.8, 25.7, 18.1, 18.0, 13.5, −4.0, −4.5, −4.6, −5.0;
5.12 (t, J = 11.1 Hz, 1H), 4.43–4.28 (m, 1H), 4.08–4.03 (m, 1H), HRMS (ESI): m/z calculated for C34H52O10N2NaSi2: [M + Na]+
3.89 (s, 3H), 3.62–3.53 (dd, J = 6.4, 10.2 Hz, 1H), 3.37–3.28 (dd, 727.3052, found 727.3054.
J = 7.7, 8.1 Hz, 1H), 2.12–1.94 (m, 1H), 1.00 (s, 9H), 0.95–0.88
(m, 12H), 0.86 (s, 9H), 0.16 (s, 3H), 0.13 (s, 3H), 0.06 (s, 3H),
0.03 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 198.0, 161.8, 156.1,
150.7, 136.4, 135.4, 133.6, 132.6, 130.2, 129.46, 129.42, 128.5,
Conclusions
128.4, 128.0, 127.8, 127.5, 127.2, 123.5, 116.6, 110.0, 78.2, 70.3, In conclusion, this sequence of chemical transformations
66.8, 65.7, 55.9, 53.9, 41.0, 26.6, 25.9, 25.5, 19.0, 18.0, 17.9, starting from D-glucose in a linear high yielding process with
12.3, −4.1, −4.5, −5.0; HRMS (ESI): m/z calculated for affordable chemicals provided differentially protected unusual
C50H73N2O9Si3: [M + H]+ 929.4618, found 929.4628.
amino acid (ADMOA, 3) present in solomonamide A in multi-
Benzyl (5R,6S,7R)-5-((R)-1-hydroxypropan-2-yl)-7-(4-methoxy- gram quantities in very efficient manner.
2-nitrobenzoyl)-2,2,3,3, 9,9,10,10-octamethyl-4,8-dioxa-3,9-di-
silaundecan-6-ylcarbamate (17). To a stirred solution of 16
(0.55 g, 0.59 mmol) in MeOH (5 mL) was added NH4F
(43.0 mg, 1.18 mmol) at 0 °C. After complete consumption of
Acknowledgements
starting material (∼4 h, by TLC analysis), methanol was evap- NK thanks CSIR, New Delhi, for a research fellowship. SC
orated and EtOAc (20 mL) was added. The organic layer was thanks CSIR, New Delhi, for funding under XII five year plan
washed with aqueous NaHCO3 solution (2 × 20 mL), water and (CSC-0108). The authors thank Dr Vemula Praveen Kumar and
brine sequentially, dried over Na2SO4 and concentrated under Dr P. S. Mainkar for useful suggestions.
reduced pressure. The obtained residue was purified by silica
gel column chromatography (pet. ether–EtOAc (3 : 1)) to give
alcohol 17 (335 mg, 82%) as viscous oil.
Notes and references
[α]2D5 = +53.8 (c = 0.06, CHCl3); IR (neat): νmax 3435, 2930,
1
2861, 1696, 1639, 1524, 683 cm−1; H NMR (CDCl3, 300 MHz):
δ 7.48–7.30 (m, 7H), 7.00–6.96 (dd, J = 2.5, 8.4 Hz, 1H),
5.16–4.98 (m, 3H), 4.70 (d, J = 4.2 Hz, 1H), 4.30–4.23 (m, 1H),
3.91–3.84 (m, 4H), 3.64–3.57 (dd, J = 7.5, 10.9 Hz, 1H),
3.38–3.32 (dd, J = 4.2, 10.9 Hz, 1H), 1.87–1.79 (m, 1H),
0.93–0.81 (m, 21H), 0.12–0.04 (m, 12H); 13C NMR (CDCl3,
75 MHz): δ 199.8, 161.5, 156.1, 148.4, 136.5, 131.6, 131.3,
128.4, 128.2, 128.0, 125.4, 118.9, 109.4, 76.9, 73.3, 66.8, 64.0,
56.0, 54.6, 38.6, 25.9, 25.8, 18.0, 14.5, −4.0, −4.3, −4.6, −5.0;
HRMS (ESI): m/z calculated for C34H54O9N2NaSi2: [M + Na]+
713.3260, found 713.3268.
1 (a) S. H. Joo, Biomol. Ther., 2012, 20, 19; (b) M. S. Butler,
Nat. Prod. Rep., 2005, 22, 162; (c) P. Thapa, M. J. Espiritu,
C. Cabalteja and J.-P. Bingham, Int. J. Pept. Res. Ther., 2014,
20, 545; (d) T. L. Simmons, E. Andrianasolo, K. McPhail,
P. Flatt and W. H. Gerwick, Mol. Cancer Ther., 2005, 4, 333.
2 (a) S. Matsunaga and N. Fusetani, Curr. Org. Chem., 2003,
7, 945; (b) Y. Nakao, S. Yoshida, S. Matsunaga, N. Shindoh,
Y. Terada, K. Nagai, J. K. Yamashita, A. Ganesan,
R. W. M. van Soest and N. Fusetani, Angew. Chem., Int. Ed.,
2006, 45, 7553; (c) H. Umezawa, T. Aoyagi, H. Morishima,
M. Matsuzaki, M. Hamada and T. Takeuchi, J. Antibiot.,
1970, 23, 259.
(2S,3R,4S,5R)-4-(Benzyloxycarbonylamino)-3,5-bis(tert-butyl-
dimethyl-silyloxy)-6-(4-methoxy-2-nitrophenyl)-2-methyl-6-oxo-
hexanoic acid (3). BAIB (280 mg, 0.87 mmol) and TEMPO
(4.5 mg, 0.03 mmol) were added sequentially to a stirred solu-
tion of alcohol 17 (200 mg, 0.29 mmol) in acetonitrile (pH = 7
buffer solution, 3 : 1, 10 mL) at rt and stirred for 6 h. The reac-
tion was quenched by the addition of saturated Na2S2O3 solu-
tion (10 mL) and then diluted with Et2O (30 mL). The
separated organic phase was washed with saturated aqueous
NaHCO3, brine, dried and concentrated under reduced
pressure. The residue was purified by column chromatography
to yield the pure acid 3 (159 mg, 78%) as clear oil.
3 H. Yu, X. Daura and W. F. van Gunsteren, Proteins, 2004,
54, 116.
4 U. Vaishampayan, M. Glode, W. Du, A. Kraft, G. Hudes,
J. Wright and M. Hussain, Clin. Cancer Res., 2000, 6, 4205.
5 R. B. Weiss, B. L. Peterson, S. L. Allen, S. M. Browning,
D. B. Duggan and C. A. Schiffer, Invest. New Drugs, 1994,
12, 41.
6 J. A. Francisco, C. G. Cerveny, D. L. Meyer, B. J. Mixan,
K. Klussman, D. F. Chace, S. X. Rejniak, K. A. Gordon,
R. DeBlanc, B. E. Toki, C.-L. Law, S. O. Doronina,
C. B. Siegall, P. D. Senter and A. F. Wahl, Blood, 2003, 102,
1458.
7 (a) E. Erba, D. Bergamaschi, L. Bassano, G. Damia,
S. Ronzoni, G. T. Faircloth and M. D’Incalci, Eur. J. Cancer,
2001, 37, 97; (b) S. Chandrasekhar, N. R. K. Reddy and
Y. S. Rao, Tetrahedron, 2006, 62, 12098.
8 C. Festa, S. De Marino, V. Sepe, M. V. D’Auria, G. Bifulco,
C. Debitus, M. Bucci, V. Vellecco and A. Zampella, Org.
Lett., 2011, 13, 1532.
[α]2D5 = +82.4 (c = 0.94, CHCl3); IR (neat): νmax 3440, 2934,
2858, 1715, 1535, 1251, 1125, 837, 694 cm−1; H NMR (CDCl3,
1
300 MHz): δ 7.68 (d, J = 8.4 Hz, 1H), 7.41–7.31 (m, 6H),
7.08–7.02 (dd, J = 2.4, 8.6 Hz, 1H), 5.12 (d, J = 9.8 Hz, 1H), 5.07
(s, 2H), 4.72 (d, J = 4.9 Hz, 1H), 4.27–4.18 (m, 1H), 4.03 (t, J =
4.7 Hz, 1H), 3.89 (s, 3H), 2.75–2.65 (m, 1H), 1.13 (d, J = 7.1 Hz,
3H), 0.87 (s, 9H), 0.84 (s, 9H), 0.11–0.02 (m, 12H); 13C NMR
(CDCl3, 75 MHz): δ 198.4, 177.8, 161.8, 155.9, 149.4, 136.4,
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2015